Fate Therapeutics (FATE) Return on Assets (2013 - 2026)
Fate Therapeutics' (FATE) quarterly Return on Assets came in at 0.01% in Q1 2026, up 1.0% YoY from 0.01% in Q1 2025, and down 2.83% on a QoQ basis from 0.01% in Q4 2025.
Fate Therapeutics (FATE) Return on Assets (2013 - 2026) Analysis & Trends
Fate Therapeutics (FATE) has 14 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Assets retreated to 0.01% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q1 2022 to a low of 0.02% in Q1 2025.
- A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
- The widest YoY moves for Return on Assets: up 1 bps in 2025, down 1 bps in 2025.
- Tracing FATE's Return on Assets over 5 years: stood at 0.01% in 2022, then retreated by 26 bps to 0.02% in 2023, then tumbled by 30 bps to 0.02% in 2024, then jumped by 51 bps to 0.01% in 2025, then dropped by 3 bps to 0.01% in 2026.
- The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |